Sectors & IndustriesHealthcareMedical Devices
Best Medical Device Stocks to Buy Now (2025)
Top medical device stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical device stocks to buy now. Learn More.

Industry: Medical Devices
D
Medical Devices is Zen Rated D and is the 100th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Zen Rating
Sentiment
Market Cap
Shares
Institutional %
Insider %
Net Insider (L12M)
Net Insider (L3M)
LIVN
LIVANOVA PLC
$3.08B54,601,07390.76%9.24%Net SellingNet Selling
BVS
BIOVENTUS INC
$611.82M82,679,04037.58%62.42%Net Selling
SNN
SMITH & NEPHEW PLC
$16.44B877,704,1863.89%0.00%
STE
STERIS PLC
$24.14B98,490,60693.69%0.94%Net SellingNet Selling
ELMD
ELECTROMED INC
$206.48M8,349,17630.72%69.28%Net Selling
EW
EDWARDS LIFESCIENCES CORP
$47.75B587,100,00085.47%1.22%Net SellingNet Selling
SNWV
SANUWAVE HEALTH INC
$356.26M8,555,61637.72%15.82%Net BuyingNet Buying
VMD
VIEMED HEALTHCARE INC
$285.85M38,785,75965.98%13.25%Net SellingNet Selling
AXGN
AXOGEN INC
$742.64M46,012,57459.10%40.90%Net SellingNet Selling
TCMD
TACTILE SYSTEMS TECHNOLOGY INC
$296.71M22,292,14576.35%23.65%Net SellingNet Selling
PODD
INSULET CORP
$23.93B70,392,53579.94%20.06%Net SellingNet Selling
MASI
MASIMO CORP
$7.59B54,324,81285.06%14.94%Net SellingNet Buying
BWAY
BRAINSWAY LTD
$292.73M37,626,42715.30%0.00%
BSX
BOSTON SCIENTIFIC CORP
$156.32B1,481,751,63490.92%5.71%Net SellingNet Selling
DXCM
DEXCOM INC
$29.54B392,155,26593.63%4.58%Net SellingNet Selling
VREX
VAREX IMAGING CORP
$479.33M41,500,00092.64%1.65%Net SellingNet Selling
IRMD
IRADIMED CORP
$921.44M12,720,00255.37%41.06%Net SellingNet Selling
SYK
STRYKER CORP
$149.64B382,307,29846.76%53.24%Net SellingNet Selling
GMED
GLOBUS MEDICAL INC
$8.27B135,057,24778.56%21.44%Net Selling
AHCO
ADAPTHEALTH CORP
$1.28B135,297,76750.12%49.88%Net SellingNet Selling
MDT
MEDTRONIC PLC
$119.05B1,282,685,88284.17%0.59%Net BuyingNet Selling
PEN
PENUMBRA INC
$10.63B38,999,12990.03%9.97%Net BuyingNet Buying
AORT
ARTIVION INC
$1.88B42,702,78579.69%20.31%Net SellingNet Selling
AVNS
AVANOS MEDICAL INC
$554.05M46,402,48195.68%4.32%Net SellingNet Buying
ITGR
INTEGER HOLDINGS CORP
$3.78B35,034,81796.29%3.71%Net SellingNet Selling
ATEC
ALPHATEC HOLDINGS INC
$2.35B147,983,77522.99%77.01%Net SellingNet Selling
TMDX
TRANSMEDICS GROUP INC
$3.92B34,090,35678.76%21.24%Net BuyingNet Buying
DCTH
DELCATH SYSTEMS INC
$385.49M34,981,25343.00%57.00%Net BuyingNet Buying
CNMD
CONMED CORP
$1.68B30,954,96397.26%2.74%Net BuyingNet Selling
ZBH
ZIMMER BIOMET HOLDINGS INC
$21.02B198,095,98475.91%24.09%Net SellingNet Selling
SIBN
SI-BONE INC
$719.16M43,140,93657.26%42.74%Net SellingNet Selling
ABT
ABBOTT LABORATORIES
$230.89B1,740,459,01479.06%1.14%Net SellingNet Selling
PHG
KONINKLIJKE PHILIPS NV
$25.51B925,009,0744.63%0.00%
BIO
BIO-RAD LABORATORIES INC
$8.06B27,062,49123.40%76.60%Net SellingNet Selling
OFIX
ORTHOFIX MEDICAL INC
$591.62M39,494,26577.98%22.02%Net BuyingNet Selling
QDEL
QUIDELORTHO CORP
$1.95B67,900,46680.89%19.11%Net SellingNet Selling
SRDX
SURMODICS INC
$486.75M14,299,26660.84%39.16%Net Selling
INMD
INMODE LTD
$944.98M63,252,00057.43%0.00%
GKOS
GLAUKOS CORP
$5.50B57,349,98767.63%32.37%Net SellingNet Buying
IRTC
IRHYTHM TECHNOLOGIES INC
$5.46B32,127,76378.05%21.95%Net SellingNet Selling
QIPT
QUIPT HOME MEDICAL CORP
$114.26M43,443,97248.13%15.48%Net Buying
ALGN
ALIGN TECHNOLOGY INC
$10.29B72,486,36885.13%14.87%Net SellingNet Buying
INGN
INOGEN INC
$216.05M27,040,39070.20%29.80%Net Selling
OM
OUTSET MEDICAL INC
$246.52M17,722,31070.36%29.64%Net SellingNet Selling
CERS
CERUS CORP
$251.13M191,698,79476.23%7.25%Net SellingNet Buying
IART
INTEGRA LIFESCIENCES HOLDINGS CORP
$1.18B77,910,79066.03%33.97%Net SellingNet Selling
SSII
SS INNOVATIONS INTERNATIONAL INC
$1.36B193,588,4100.13%62.42%Net Buying
ANIK
ANIKA THERAPEUTICS INC
$135.24M14,418,09082.64%17.36%Net SellingNet Selling
BFLY
BUTTERFLY NETWORK INC
$405.30M251,741,09046.53%38.05%Net SellingNet Buying
INSP
INSPIRE MEDICAL SYSTEMS INC
$2.77B29,574,31666.47%33.53%Net SellingNet Buying
PTHL
PHETON HOLDINGS LTD
$10.40M14,250,0000.01%0.00%
IINN
INSPIRA TECHNOLOGIES OXY BHN LTD
$27.89M24,252,0960.62%0.00%
BRKR
BRUKER CORP
$5.16B151,719,36552.45%47.55%Net BuyingNet Selling
NVCR
NOVOCURE LTD
$1.38B111,799,29059.04%40.96%Net BuyingNet Buying
UFPT
UFP TECHNOLOGIES INC
$1.62B7,711,12687.59%12.41%Net SellingNet Buying
SGHT
SIGHT SCIENCES INC
$209.91M51,702,08840.80%58.51%Net BuyingNet Buying
TNON
TENON MEDICAL INC
$11.01M8,879,2201.40%43.91%
PRCT
PROCEPT BIOROBOTICS CORP
$2.23B55,635,94175.78%24.22%Net SellingNet Selling
LUCD
LUCID DIAGNOSTICS INC
$136.68M108,477,49517.45%34.47%Net BuyingNet Buying
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA INC
$393.49M300,370,61165.15%7.72%Net SellingNet Selling
CBLL
CERIBELL INC
$433.73M36,663,96870.67%29.33%Net BuyingNet Selling
NPCE
NEUROPACE INC
$302.70M33,081,49844.29%55.71%Net SellingNet Selling
KIDS
ORTHOPEDIATRICS CORP
$535.57M25,073,60243.27%56.73%Net SellingNet Buying
BSGM
BIOSIG TECHNOLOGIES INC
$150.18M31,418,79550.62%49.38%
NUWE
NUWELLIS INC
$4.60M902,6652.37%97.63%Net BuyingNet Buying
CV
CAPSOVISION INC
$175.40M46,774,0670.00%4.01%Net BuyingNet Buying
CTKB
CYTEK BIOSCIENCES INC
$526.71M127,223,77862.41%22.36%Net SellingNet Selling
TMCI
TREACE MEDICAL CONCEPTS INC
$463.69M63,173,12647.37%52.63%Net BuyingNet Buying
HSDT
HELIUS MEDICAL TECHNOLOGIES INC
$6.59M1,077,2570.93%99.07%
MASS
908 DEVICES INC
$225.54M36,085,69853.21%46.79%Net BuyingNet Selling
LUNG
PULMONX CORP
$69.68M40,746,55685.62%14.38%Net SellingNet Buying
INBS
INTELLIGENT BIO SOLUTIONS INC
$14.55M8,979,1527.88%19.23%
ARAY
ACCURAY INC
$171.27M112,677,14764.27%35.73%Net SellingNet Buying
AIMD
AINOS INC
$17.79M4,657,8610.03%99.97%Net BuyingNet Selling
HIND
VYOME HOLDINGS INC
$6.19M673,3340.09%99.91%
VTAK
CATHETER PRECISION INC
$3.07M1,227,76411.01%88.99%Net Selling
BDMD
BAIRD MEDICAL INVESTMENT HOLDINGS LTD
$87.54M35,728,6251.51%17.26%
HYPR
HYPERFINE INC
$97.44M78,581,00113.73%34.31%Net SellingNet Selling
TNDM
TANDEM DIABETES CARE INC
$845.29M67,569,47168.38%31.62%Net SellingNet Buying
ESTA
ESTABLISHMENT LABS HOLDINGS INC
$1.19B28,917,25481.33%18.67%Net SellingNet Buying
RPID
RAPID MICRO BIOSYSTEMS INC
$106.55M44,210,32832.78%67.22%Net SellingNet Selling
SMLR
SEMLER SCIENTIFIC INC
$438.81M14,804,69362.02%37.98%Net BuyingNet Buying
CARL
CARLSMED INC
$353.53M26,581,1340.00%54.33%Net BuyingNet Buying
ECOR
ELECTROCORE INC
$40.27M7,583,4458.27%91.73%Net BuyingNet Buying
CLPT
CLEARPOINT NEURO INC
$298.20M28,427,41732.20%26.46%Net SellingNet Selling
TLSI
TRISALUS LIFE SCIENCES INC
$260.31M49,867,27917.23%41.95%Net Buying
XAIR
BEYOND AIR INC
$11.60M5,226,21346.17%53.83%Net BuyingNet Buying
SRTS
SENSUS HEALTHCARE INC
$55.73M16,440,03626.40%31.37%Net BuyingNet Buying
ICCM
ICECURE MEDICAL LTD
$65.65M58,616,2760.43%0.00%
RCEL
AVITA MEDICAL INC
$114.73M26,434,65829.07%3.95%Net BuyingNet Buying
SI
SHOULDER INNOVATIONS INC
N/A19,923,4610.00%58.36%Net BuyingNet Buying
BBNX
BETA BIONICS INC
$818.98M43,470,12591.21%8.79%Net BuyingNet Buying
NAOV
NANOVIBRONIX INC
$4.35M796,9502.45%70.80%
QTRX
QUANTERIX CORP
$176.67M38,829,38664.36%35.64%Net BuyingNet Buying
NVNO
ENVVENO MEDICAL CORP
$15.38M19,247,14126.40%58.75%Net Buying
NNOX
NANO-X IMAGING LTD
$247.29M63,900,00019.63%0.00%
HSCS
HEARTSCIENCES INC
$6.60M1,934,2803.12%1.66%Net SellingNet Selling
CVRX
CVRX INC
$205.29M26,151,72440.41%59.59%Net Buying
AMIX
AUTONOMIX MEDICAL INC
$5.76M5,145,6972.58%97.42%
AEMD
AETHLON MEDICAL INC
$4.86M2,598,7111.22%98.78%Net BuyingNet Selling

Medical Device Stocks FAQ

What are the best medical device stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best medical equipment stocks to buy right now are:

1. Livanova (NASDAQ:LIVN)


Livanova (NASDAQ:LIVN) is the #1 top medical device stock out of 141 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Livanova (NASDAQ:LIVN) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: A.

Livanova (NASDAQ:LIVN) has a Due Diligence Score of 17, which is -10 points lower than the medical device industry average of 27. Although this number is below the industry average, our proven quant model rates LIVN as a "A".

LIVN passed 5 out of 33 due diligence checks and has weak fundamentals. Livanova has seen its stock return 12.2% over the past year, overperforming other medical device stocks by 44 percentage points.

Livanova has an average 1 year price target of $59.60, an upside of 5.73% from Livanova's current stock price of $56.37.

Livanova stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Livanova, 20% have issued a Strong Buy rating, 60% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Bioventus (NASDAQ:BVS)


Bioventus (NASDAQ:BVS) is the #2 top medical device stock out of 141 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: B, Momentum: C, Sentiment: C, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 21, which is -6 points lower than the medical device industry average of 27. Although this number is below the industry average, our proven quant model rates BVS as a "A".

BVS passed 7 out of 33 due diligence checks and has weak fundamentals. Bioventus has seen its stock lose -25.1% over the past year, overperforming other medical device stocks by 7 percentage points.

Bioventus has an average 1 year price target of $13.50, an upside of 82.43% from Bioventus's current stock price of $7.40.

Bioventus stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Smith & Nephew (NYSE:SNN)


Smith & Nephew (NYSE:SNN) is the #3 top medical device stock out of 141 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Smith & Nephew (NYSE:SNN) is: Value: B, Growth: B, Momentum: B, Sentiment: C, Safety: B, Financials: B, and AI: C.

Smith & Nephew (NYSE:SNN) has a Due Diligence Score of 42, which is 15 points higher than the medical device industry average of 27.

SNN passed 15 out of 38 due diligence checks and has strong fundamentals. Smith & Nephew has seen its stock return 21% over the past year, overperforming other medical device stocks by 53 percentage points.

Smith & Nephew has an average 1 year price target of $36.00, a downside of -3.87% from Smith & Nephew's current stock price of $37.45.

Smith & Nephew stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Smith & Nephew, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the medical device stocks with highest dividends?

Out of 7 medical device stocks that have issued dividends in the past year, the 3 medical device stocks with the highest dividend yields are:

1. Smith & Nephew (NYSE:SNN)


Smith & Nephew (NYSE:SNN) has an annual dividend yield of 2%, which is 1 percentage points higher than the medical device industry average of 1.03%. Smith & Nephew's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Smith & Nephew's dividend has shown consistent growth over the last 10 years.

Smith & Nephew's dividend payout ratio of 66.7% indicates that its dividend yield is sustainable for the long-term.

2. Abbott Laboratories (NYSE:ABT)


Abbott Laboratories (NYSE:ABT) has an annual dividend yield of 1.3%, which is the same as the medical device industry average of 1.03%. Abbott Laboratories's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Abbott Laboratories's dividend has shown consistent growth over the last 10 years.

Abbott Laboratories's dividend payout ratio of 29% indicates that its dividend yield is sustainable for the long-term.

3. Conmed (NYSE:CNMD)


Conmed (NYSE:CNMD) has an annual dividend yield of 1.1%, which is the same as the medical device industry average of 1.03%. Conmed's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Conmed's dividend has not shown consistent growth over the last 10 years.

Conmed's dividend payout ratio of 22.5% indicates that its dividend yield is sustainable for the long-term.

Why are medical device stocks up?

Medical device stocks were up 0.25% in the last day, and down -1.3% over the last week. Movano was the among the top gainers in the medical devices industry, gaining 73.14% yesterday.

Movano Health shares are trading higher after the company was granted a Nasdaq extension to regain compliance with filing by September 30 and $1 bid price rules by October 30, 2025.

What are the most undervalued medical device stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued medical device stocks right now are:

1. Inmode (NASDAQ:INMD)


Inmode (NASDAQ:INMD) is the most undervalued medical device stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Inmode has a valuation score of 71, which is 56 points higher than the medical device industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Inmode's stock has dropped -6.63% in the past year. It has overperformed other stocks in the medical device industry by 25 percentage points.

2. Conmed (NYSE:CNMD)


Conmed (NYSE:CNMD) is the second most undervalued medical device stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Conmed has a valuation score of 43, which is 28 points higher than the medical device industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Conmed's stock has dropped -26.5% in the past year. It has overperformed other stocks in the medical device industry by 5 percentage points.

3. Adapthealth (NASDAQ:AHCO)


Adapthealth (NASDAQ:AHCO) is the third most undervalued medical device stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Adapthealth has a valuation score of 71, which is 56 points higher than the medical device industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Adapthealth's stock has dropped -14.27% in the past year. It has overperformed other stocks in the medical device industry by 18 percentage points.

Are medical device stocks a good buy now?

51.4% of medical device stocks rated by analysts are a strong buy right now. On average, analysts expect medical device stocks to rise by 27.92% over the next year.

6.36% of medical device stocks have a Zen Rating of A (Strong Buy), 16.36% of medical device stocks are rated B (Buy), 42.73% are rated C (Hold), 26.36% are rated D (Sell), and 8.18% are rated F (Strong Sell).

What is the average p/e ratio of the medical devices industry?

The average P/E ratio of the medical devices industry is 32.17x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.